Thomas A MCCOURT insider trades: Ironwood Pharmaceuticals (IRWD) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Thomas reports to the SEC
Open-market buys and sales
36 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Feb 24, 2026 | IRWD | ↓ Sell | 198,283 | $3.73 | $740K | Direct | Feb 25, 2026 (1d) |
| May 16, 2025 | IRWD | ↓ Sell | 13,353 | $0.58 | $8K | Direct | May 20, 2025 (4d) |
| Feb 10, 2025 | IRWD | ↓ Sell | 139,064 | $1.76 | $245K | Direct | Feb 12, 2025 (2d) |
| May 20, 2024 | IRWD | ↓ Sell | 67,618 | $6.45 | $436K | Direct | May 22, 2024 (2d) |
| Feb 12, 2024 | IRWD | ↓ Sell | 177,164 | $15.24 | $2.7M | Direct | Feb 14, 2024 (2d) |
| May 30, 2023 | IRWD | ↓ Sell | 26,632 | $10.70 | $285K | Direct | Jun 1, 2023 (2d) |
| May 22, 2023 | IRWD | ↓ Sell | 36,000 | $10.12 | $364K | Direct | May 24, 2023 (2d) |
| May 8, 2023 | IRWD | ↓ Sell | 21,148 | $10.62 | $225K | Direct | May 10, 2023 (2d) |
| Mar 27, 2023 | IRWD | ↓ Sell | 46,129 | $10.67 | $492K | Direct | Mar 29, 2023 (2d) |
| Mar 3, 2023 | IRWD | ↓ Sell | 33,756 | $11.22 | $379K | Direct | Mar 7, 2023 (4d) |
| Feb 28, 2023 | IRWD | ↓ Sell | 61,231 | $11.36 | $696K | Direct | Mar 1, 2023 (1d) |
| Jan 5, 2023 | IRWD | ↓ Sell | 110,962 | $12.07 | $1.3M | Direct | Jan 9, 2023 (4d) |
| Oct 3, 2022 | IRWD | ↓ Sell | 18,899 | $10.41 | $197K | Direct | Oct 5, 2022 (2d) |
| Sep 1, 2022 | IRWD | ↓ Sell | 26,446 | $10.65 | $282K | Direct | Sep 6, 2022 (5d) |
| Aug 1, 2022 | IRWD | ↓ Sell | 23,229 | $11.35 | $264K | Direct | Aug 3, 2022 (2d) |
| Jun 30, 2022 | IRWD | ↓ Sell | 19,959 | $11.58 | $231K | Direct | Jul 5, 2022 (5d) |
| May 23, 2022 | IRWD | ↓ Sell | 36,308 | $11.50 | $418K | Direct | May 25, 2022 (2d) |
| Feb 28, 2022 | IRWD | ↓ Sell | 48,424 | $10.77 | $522K | Direct | Mar 2, 2022 (2d) |
| Dec 22, 2021 | IRWD | ↓ Sell | 46,327 | $11.41 | $529K | Direct | Dec 23, 2021 (1d) |
| Nov 23, 2021 | IRWD | ↓ Sell | 52,644 | $11.58 | $610K | Direct | Nov 24, 2021 (1d) |
| May 24, 2021 | IRWD | ↓ Sell | 1,716 | $12.25 | $21K | Direct | May 26, 2021 (2d) |
| Apr 19, 2021 | XLRN | ↓ Sell | 7,500 | $119.26 | $894K | Direct | Apr 21, 2021 (2d) |
| Feb 26, 2021 | IRWD | ↓ Sell | 14,685 | $9.11 | $134K | Direct | Mar 2, 2021 (4d) |
| Sep 11, 2020 | XLRN | ↓ Sell | 23,272 | $90.39 | $2.1M | Direct | Sep 15, 2020 (4d) |
| May 11, 2020 | IRWD | ↓ Sell10b5-1 | 1,697 | $10.35 | $18K | Direct | May 13, 2020 (2d) |
| Feb 21, 2020 | IRWD | ↓ Sell10b5-1 | 4,177 | $11.63 | $49K | Direct | Feb 25, 2020 (4d) |
| Jan 24, 2020 | IRWD | ↓ Sell | 20,000 | $12.71 | $254K | Direct | Jan 28, 2020 (4d) |
| Aug 30, 2019 | IRWD | ↓ Sell | 220,000 | $9.24 | $2.0M | Direct | Sep 4, 2019 (5d) |
| May 10, 2019 | IRWD | ↓ Sell10b5-1 | 4,055 | $10.53 | $43K | Direct | May 14, 2019 (4d) |
| Feb 21, 2019 | IRWD | ↓ Sell10b5-1 | 4,841 | $14.31 | $69K | Direct | Feb 22, 2019 (1d) |
| Jul 6, 2018 | IRWD | ↓ Sell | 30,000 | $20.00 | $600K | Direct | Jul 10, 2018 (4d) |
| Feb 21, 2018 | IRWD | ↓ Sell10b5-1 | 3,343 | $14.66 | $49K | Direct | Feb 22, 2018 (1d) |
| May 15, 2017 | IRWD | ↓ Sell | 30,000 | $18.20 | $546K | Direct | May 16, 2017 (1d) |
| Feb 22, 2017 | IRWD | ↓ Sell10b5-1 | 1,520 | $16.94 | $26K | Direct | Feb 24, 2017 (2d) |
| Feb 24, 2016 | IRWD | ↓ Sell10b5-1 | 1,600 | $8.50 | $14K | Direct | Feb 26, 2016 (2d) |
| Mar 11, 2013 | IRWD | ↓ Sell | 40,000 | $17.00 | $680K | Direct | Mar 13, 2013 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other IRWD insiders
Open-market trades in the last 12 months
About Thomas A MCCOURT's insider trades
Thomas A MCCOURT is Chief Executive Officer at Ironwood Pharmaceuticals (IRWD). Since Mar 11, 2013, Thomas has reported no open-market purchases and 36 sales worth $18.5M on SEC Form 4. In the last 12 months: 1 sale ($740K).
7 sales (1% of the value sold) were made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so they say little about how the insider sees the stock today.
Their filings also include grants and awards (38 filings), option exercises (10 filings), other transactions (2 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every IRWD insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.